Screener
BridgeBio Pharma BBIO Reportable Segment — Other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Noncash interest expense on deferred royalty obligations (1) | (39,873) | (24,020) |
| Loss on extinguishment of debt | — | (21,155) |
| Net loss from equity method investments | (18,283) | (15,556) |
| Other income, net | 4,253 | 8,231 |
| Total other expense, net | (60,599) | (65,236) |
| Net loss | (166,555) | (169,608) |
| Net loss attributable to redeemable convertible noncontrolling interests and noncontrolling interests | 2,512 | 2,186 |
| Segment net loss attributable to common stockholders of BridgeBio | $(164,043) | $(167,422) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BridgeBio Pharma's reportable segment — other income, net?
- BridgeBio Pharma (BBIO) reported reportable segment — other income, net of $4.25M in Q1 2026.
- How has BridgeBio Pharma's reportable segment — other income, net changed year-over-year?
- BridgeBio Pharma's reportable segment — other income, net decreased by 48.3% year-over-year, from $8.23M to $4.25M.
- What does reportable segment — other income, net mean?
- This category captures miscellaneous income and expense items that are not directly related to the company's core operating activities. It typically includes items such as foreign currency exchange gains or losses, interest income from cash equivalents, and other non-recurring financial gains. It serves as a catch-all for secondary financial activities that impact the bottom line.
Ask your AI about BridgeBio Pharma's reportable segment — other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude